SCHEDULE 13G

Company

Traws Pharma, Inc.

Filed

November 26, 2019

Accession Number

0000899140-19-000626

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →